Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 265,000 | 258,000 | 268,000 | 274,000 | 258,000 |
| Cost of Goods | 19,000 | 28,000 | 25,000 | 33,000 | 21,000 |
| Gross Profit | 246,000 | 230,000 | 243,000 | 241,000 | 237,000 |
| Operating Expenses | 118,000 | 158,000 | 364,000 | 144,000 | 136,000 |
| Operating Income | 128,000 | 72,000 | -121,000 | 97,000 | 101,000 |
| Interest Expense | 12,000 | 13,000 | 12,000 | 11,000 | 15,000 |
| Other Income | 1,000 | 0 | 0 | 0 | 0 |
| Pre-tax Income | 117,000 | 59,000 | -133,000 | 86,000 | 86,000 |
| Income Tax | 37,000 | -18,000 | 16,000 | 29,000 | 36,000 |
| Net Income Continuous | 80,000 | 77,000 | -149,000 | 57,000 | 50,000 |
| Net Income | $80,000 | $77,000 | $-149,000 | $57,000 | $50,000 |
| EPS Basic Total Ops | 0.55 | 0.55 | -1.05 | 0.40 | 0.35 |
| EPS Basic Continuous Ops | 0.56 | 0.53 | -1.03 | 0.40 | 0.35 |
| EPS Diluted Total Ops | 0.55 | 0.50 | -1.00 | 0.40 | 0.35 |
| EPS Diluted Continuous Ops | 0.53 | 0.51 | -1.00 | 0.38 | 0.34 |
| EBITDA(a) | $130,000 | $74,000 | $-121,000 | $103,000 | $107,000 |